To test this hypothesis, we investigated the influence of the ADAMTS13 rs2285489 SNP on transplant outcomes in a cohort of patients undergoing unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies through the Japan Marrow Donor Program (JMDP). The gene discussed is ADAMTS13; the disease is hematologic disorder.